Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12;14(12):4183.
doi: 10.3390/jcm14124183.

Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal Women

Affiliations

Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal Women

Hiroyuki Honda et al. J Clin Med. .

Abstract

Objectives: Equol, a gut-derived metabolite of soy isoflavones with estrogenic activity, may influence bladder aging. However, the association between overactive bladder (OAB), which is closely linked to bladder aging, and the estrogenic effects of equol remains unknown. Therefore, this study investigated the association between endogenous equol production and onset and severity of OAB in postmenopausal women. Methods: The study included 128 postmenopausal women, newly diagnosed with OAB, who were categorized into equol- and non-equol-producing groups based on urinary equol levels as measured by enzyme-linked immunosorbent assay. Patient clinical characteristics, OAB Symptom Score (OABSS), and urodynamic parameters were assessed. Propensity score matching was performed to minimize confounding factors related to the timing of lower urinary tract symptom (LUTS) onset. Results: Equol producers exhibited a significantly later onset of LUTS than non-producers (68.7 ± 10.9 vs. 62.7 ± 10.7 years, p = 0.002). Equol producers were more prevalent in the late-onset group (58.6% vs. 31.0%, p = 0.002), which had significantly higher urinary equol concentrations than the early-onset group (p = 0.014). No significant differences were observed in total OABSS or subscale scores between the groups, suggesting that equol did not affect symptom severity. Propensity score-matched analysis (n = 104) confirmed that equol non-production was an independent risk factor for early-onset LUTS (OR, 1.930; 95% CI, 1.248-4.049; p = 0.014). Conclusions: Endogenous equol production was significantly associated with the delayed onset of OAB in postmenopausal women. Thus, equol may serve as a protective factor and non-invasive biomarker to guide individualized prevention and early intervention strategies in urological care for women.

Keywords: equol; lower urinary tract symptom; menopause; overactive bladder; women.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Patient flow diagram.

Similar articles

References

    1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., Wein A., Standardisation Sub-Committee of the International Continence Society The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society. Neurourol. Urodyn. 2002;21:167–178. doi: 10.1002/nau.10052. - DOI - PubMed
    1. Qudah S., Abufaraj M., Farah R., Almazeedi A., Ababneh A., Alnabulsi M., Qatawneh A., Hyassat D., Ajlouni K. The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study. Arab J. Urol. 2024;22:39–47. doi: 10.1080/2090598X.2023.2221403. - DOI - PMC - PubMed
    1. Mitsui T., Sekido N., Masumori N., Haga N., Omae K., Saito M., Kubota Y., Sakakibara R., Yoshida M., Takahashi S. Prevalence and impact on daily life of lower urinary tract symptoms in Japan: Results of the 2023 Japan Community Health Survey (JaCS 2023) Int. J. Urol. 2024;31:747–754. doi: 10.1111/iju.15454. - DOI - PMC - PubMed
    1. Angelou K., Grigoriadis T., Diakosavvas M., Zacharakis D., Athanasiou S. The genitourinary syndrome of menopause: An overview of the recent data. Cureus. 2020;12:e7586. doi: 10.7759/cureus.7586. - DOI - PMC - PubMed
    1. Ramezani Tehrani F., Mousavi M., Saei Ghare Naz M., Noroozzadeh M., Azizi F., Farahmand M. Endogenous estrogen exposure and hypertension risk; A population-based cohort study with about 2 decades of follow-up. J. Clin. Endocrinol. Metab. 2025;110:e1125–e1133. doi: 10.1210/clinem/dgae316. - DOI - PubMed

LinkOut - more resources